FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for Lunesta (eszopiclone) from Waylis Therapeutics LLC, resulting in a label change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Lunesta (eszopiclone)

Snippet

SUPPL AP for LUNESTA (ESZOPICLONE)